# Ypsomed plans over CHF 100 million expansion of autoinjector production at Solothurn

Ypsomed plans to invest more than CHF 100 million over the next four years to expand autoinjector production capacities at its Solothurn site, including doubling the capacity for injection moulding tool shop facilities.

- Type: Expansion
- Announced: 2024-03-28
- Where: Solothurn, Switzerland
- Value: $110.0M (100.0M CHF)
- Status: announced
- Products: autoinjectors
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md)

## Sources

- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/ypsomed-pen-needle-mtd/), 2024-03-28: "Over the next four years, Ypsomed plans to invest more than SFr100m to expand autoinjector production capacities at its Solothurn site."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.